Delivery Order SPE2DR25D1053-SPE2DR26FT730
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $14,433.09. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,124.59 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on April 24, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 25, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,387.60. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of September 22, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packaging) under a firm fixed-price contract with a ceiling value of $2,564.82. This is a non-set-aside competitive award with an ultimate completion date of August 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $34,561.46 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $24,226.79 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) valued at $5,818.86 under a firm fixed price contract type. This non-set-aside award was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The products will be delivered to Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $11.89K delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This competitively awarded, firm fixed-price delivery order is set to be completed by July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,231.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count). This contract, which is a child award under a larger vehicle, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages). This competitive, non-set-aside contract is valued at $70,553.66 with firm fixed pricing and an ultimate completion date of September 29, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT730Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count) valued at $9,272.88 under a firm fixed-price contract with an ultimate completion date of November 10, 2025. This is a non-set-aside competitive award to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company holds a significant $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical extending through December 2026, which provides a comprehensive global pharmaceutical support vehicle for supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for NURTEC ODT, a migraine treatment medication, exemplifies the company's ongoing role in fulfilling federal pharmaceutical supply requirements through competitively awarded orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 11/7/25 |